This drug developed by AI for lungs disease enters human clinical trials
The use case scenario of artificial intelligence is growing faster than expected. AI is being used in several key industries to make things more efficient and effective. The latest industry to become onboard on AI-based systems is the pharma industry and recently a drug for curing liver disease known as Idiopathic Pulmonary Fibrosis (IPF), a disease that causes scarring in the lungs, has been discovered and designed using artificial intelligence has entered into human clinical trials. Clinical trial for INS018_55 has…